Literature DB >> 31058483

Promoting Oxidative Stress in Cancer Starvation Therapy by Site-Specific Startup of Hyaluronic Acid-Enveloped Dual-Catalytic Nanoreactors.

Zhigang Yao1, Benhua Zhang1, Tingxizi Liang1, Jie Ding1,2, Qianhao Min1, Jun-Jie Zhu1.   

Abstract

Cutting off the glucose supply by glucose oxidase (GOx) has been regarded as an emerging strategy in cancer starvation therapy. However, the standalone GOx delivery suffered suboptimal potency for tumor elimination and potential risks of damaging vasculatures and normal organs during transportation. To enhance therapeutic efficacy and tumor specificity, a site-specific activated dual-catalytic nanoreactor was herein constructed by embedding GOx and ferrocene in hyaluronic acid (HA)-enveloped dendritic mesoporous silica nanoparticles to promote intratumoral oxidative stress in cancer starvation. In this nanoreactor, the encapsulated GOx served as the primary catalyst that accelerated oxidation of glucose and generation of H2O2, while the covalently linked ferrocene worked as the secondary catalyst for converting the upstream H2O2 to more toxic hydroxyl radicals (•OH) via a classic Fenton reaction. The outmost HA shell not only offered a shielding layer for preventing blood glucose from oxidation during nanoreactor transportation, thus minimizing the probable oxidative damage to normal tissues, but also imparted the nanoreactor with targeting ability for facilitating its internalization into CD44-overexpressing tumor cells. After the nanoreactor was endocytosed by target cells, the HA shell underwent hyaluronidase-triggered degradation in lysosomes and switched on the cascade catalytic reaction mediated by GOx and ferrocene. The resulting glucose exhaustion and •OH accumulation would effectively kill cancer cells and suppress tumor growth via combination of starvation and oxidative stress enhancement. Both in vitro and in vivo results indicated the significantly amplified therapeutic effects of this synergistic therapeutic strategy based on the dual-catalytic nanoreactor. Our study provides a new avenue for engineering therapeutic nanoreactors that take effect in a tumor-specific and orchestrated fashion for cancer starvation therapy.

Entities:  

Keywords:  Fenton reaction; dual-catalytic nanoreactors; oxidative stress; site-specific; starvation therapy

Mesh:

Substances:

Year:  2019        PMID: 31058483     DOI: 10.1021/acsami.9b06034

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  4 in total

Review 1.  Glucose Metabolism Intervention-Facilitated Nanomedicine Therapy.

Authors:  Zhiyan Li; Xianghui Li; Shichao Ai; Song Liu; Wenxian Guan
Journal:  Int J Nanomedicine       Date:  2022-06-17

2.  Polysulfated Hyaluronan GlycoMira-1111 Inhibits Elastase and Improves Rheology in Cystic Fibrosis Sputum.

Authors:  Apparao B Kummarapurugu; Shuo Zheng; Abigail Pulsipher; Justin R Savage; Jonathan Ma; Bruce K Rubin; Thomas P Kennedy; Judith A Voynow
Journal:  Am J Respir Cell Mol Biol       Date:  2021-02       Impact factor: 6.914

Review 3.  Advances in nanomedicine for cancer starvation therapy.

Authors:  Shuangjiang Yu; Zhaowei Chen; Xuan Zeng; Xuesi Chen; Zhen Gu
Journal:  Theranostics       Date:  2019-10-17       Impact factor: 11.556

Review 4.  Chemodynamic nanomaterials for cancer theranostics.

Authors:  Jingqi Xin; Caiting Deng; Omer Aras; Mengjiao Zhou; Chunsheng Wu; Feifei An
Journal:  J Nanobiotechnology       Date:  2021-06-28       Impact factor: 10.435

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.